Figure 9.
The sheet morphology of melanosomal amyloid essentially depends on functional O-glycosylation. Mel220 transfectants expressing human PMEL were treated for four days with the O-glycosylation inhibitor Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside or with the solvent DMSO alone. (A–C) Western blot analysis of SDS-lysed total membranes using PMEL-specific antibodies EPR4864 (PMEL C-term.) (A), HMB45 (sialylated RPT domain) (B, two different exposures of the same blot are shown), and 6777 (CAF) (C). (D,E) Quantitative EM analysis showing the number of fibril-containing organelles per cell [N = 15]. An unpaired two-tailed t-test was used to determine whether means are statistically different from the DMSO-treated sample (NS, not significant) (D). Representative electron micrographs are depicted (E). Quantification of the number of fibril-containing organelles displaying the collapsed amyloid sheet phenotype. Shown is the average from three independent experiments. An unpaired two-tailed t-test was used to determine whether means are statistically different from the DMSO-treated sample (***p < 0.0001) (E, lower panel).